METASTATIC MALIGNANT NEOPLASM IN THE SOFT TISSUE

Clinical trials for METASTATIC MALIGNANT NEOPLASM IN THE SOFT TISSUE explained in plain language.

Never miss a new study

Get alerted when new METASTATIC MALIGNANT NEOPLASM IN THE SOFT TISSUE trials appear

Sign up with your email to follow new studies for METASTATIC MALIGNANT NEOPLASM IN THE SOFT TISSUE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Major trial aims to boost survival for advanced kidney cancer

Disease control Ongoing

This large, late-stage trial is testing if adding a drug called cabozantinib to a standard immunotherapy regimen helps patients with advanced kidney cancer that has spread. The study will compare how long patients live and how long their cancer is controlled on the new combinatio…

Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE SOFT TISSUE

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 11, 2026 14:54 UTC

METASTATIC MALIGNANT NEOPLASM IN THE SOFT TISSUE

Get alerted when new METASTATIC MALIGNANT NEOPLASM IN THE SOFT TISSUE trials appear

Major trial aims to boost survival for advanced kidney cancer